National philanthropist, best-selling author, award-winning filmmaker, acclaimed speaker, and global media executive, Dr. Cheryl Polote Williamson, will honor 17 Black women business owners and ...
Alumis Inc. is drawing attention with a major share sale and bullish analyst forecasts. The firm aims to fund its immune ...
In addition, Alumis has granted the underwriters a 30-day option to purchase up to an additional 2,647,500 shares of common stock at the public offering price, less underwriting discounts and ...
Zacks Investment Research on MSN
ALMS Surges as Envudeucitinib Meets Goals in Plaque Psoriasis Studies
Shares of Alumis ALMS surged 95.3% on Jan. 6, after the company announced positive top-line data from its two phase III ...
Barchart on MSN
Should you chase the rally in Alumis stock today?
Alumis (ALMS) stock exploded higher on Tuesday after the biotech firm reported promising Phase 3 results for envudeucitinib, ...
Alumis Inc. surged on Phase 3 psoriasis data for envudeucitinib. Click for this look at ALMS stock and why I am bullish on ...
Alumis Inc. (NASDAQ: ALMS) shares shot up 132% to $19.30 after the company said topline results from its Phase 3 ONWARD1 and ...
Alumis (ALMS) stock is soaring after the company announced positive trial results for its plaque psoriasis drug ...
Alumis said on Tuesday its experimental drug met the main goal of improving symptoms of a common skin disease in two late-stage studies, powering its shares to a record high and more than doubling ...
Alumis (ALMS) stock surged after two Phase 3 trial for its lead drug, envudeucitinib, succeeded against plaque psoriasis.
Hamilton County sold its Jobs and Family Services building in Over-the-Rhine for $12.1 million. The historic Alms & Doepke building will be redeveloped into over 150 apartments, a cafe, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback